RepliCel Life Ownership

RepliCel Life owns a total of 73.58 Million outstanding shares. RepliCel Life has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as RepliCel Life in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of RepliCel Life, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Dividend Paid And Capex Coverage Ratio is likely to climb to -2,174 in 2024. Common Stock Shares Outstanding is likely to climb to about 62.2 M in 2024, whereas Net Loss is likely to drop (4.9 M) in 2024. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.